- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07699055
tACS Alters EEG Microstates in DoC
Transcranial Alternating Current Stimulation Is Associated With Changes in EEG Microstate Dynamics in Disorders of Consciousness
Disorders of consciousness (DoC), including unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), remain difficult to diagnose at the bedside. Electroencephalography (EEG) microstate analysis provides a high-temporal-resolution approach for characterizing large-scale resting-state brain dynamics, and its application in neuromodulation studies remains under investigation.
This study is designed to investigate the effects of a single 20-minute session of 40 Hz transcranial alternating current stimulation (tACS) applied over the bilateral dorsolateral prefrontal cortex (DLPFC) on resting-state EEG microstate parameters in patients with DoC. Participants undergo resting-state EEG recordings immediately before and after a 2 mA, 40 Hz bilateral DLPFC tACS session. EEG microstate maps (A-G) are identified by back-fitting to individual recordings, and microstate parameters including mean duration, occurrence, coverage, and global explained variance (GEV) are calculated. Behavioral assessments are performed using the Coma Recovery Scale-Revised (CRS-R) and the Simplified Evaluation of CONsciousness Disorders (SECONDs). The study aims to characterize changes in EEG microstate dynamics following tACS and to examine their associations with behavioral measures of consciousness.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Bağcılar
-
Istanbul, Bağcılar, Turquie (Türkiye)
- Medipol Mega University Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Adults aged 18 years or older.
- Medically stable at the time of assessment.
- No administration of sedative or hypnotic medication within the previous 24 hours.
- Preserved wakefulness (spontaneous or elicited by stimulation) with reduced or absent awareness, consistent with Unresponsive Wakefulness Syndrome (UWS) or Minimally Conscious State (MCS).
- Diagnosis confirmed by an experienced neurologist using repeated clinical assessments with the Coma Recovery Scale-Revised (CRS-R) and the Simplified Evaluation of CONsciousness Disorders (SECONDs) performed on different days and at different times during periods of wakefulness.
Exclusion Criteria:
- Acute phase of brain injury (within the first 28 days after injury).
- Administration of sedative or hypnotic medication within the previous 24 hours.
- Medical instability (e.g., active infection or hemodynamic instability).
- Epileptic seizures uncontrolled despite anticonvulsant therapy.
- Serious systemic illnesses that could affect the level of consciousness (e.g., sepsis or end-stage organ failure).
- Brain death or coma without any evidence of wakefulness.
- A previous history of developmental disorders, major neurological disorders, or severe psychiatric disorders associated with significant functional impairment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Disorders of Consciousness and TACS
We evaluated the effect of a single 20-minute session of 40 Hz transcranial alternating current stimulation (tACS) over the bilateral dorsolateral prefrontal cortex (DLPFC) on resting-state EEG microstate parameters in DoC and their relationships with behavioral consciousness scores.
|
After completion of the first 20-minute resting-state EEG, tACS was applied using a Neurosoft / Neurostim device.
Stimulation was performed at the 40 Hz gamma frequency, with two stimulation electrodes placed bilaterally over the DLPFC.
According to the international 10-20 system, this placement corresponded to the F3 (left DLPFC) and F4 (right DLPFC) electrode positions.
The stimulation lasted 20 minutes, and a constant current intensity of 2 mA was used throughout.
The current was delivered as a sinusoidal waveform without phase shifting or modulation.
The electrodes were sponge-based pads measuring 5 × 7 cm each.
To improve conductivity and ensure homogeneous skin contact, the sponge electrodes were moistened with 0.9% isotonic sodium chloride (saline).
Electrodes were secured to the skin to optimize contact quality and homogenize current distribution.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Resting-State EEG Microstate Parameters
Délai: Baseline and immediately after the 20-minute tACS session.
|
EEG recordings were obtained in different settings according to the patient's physical condition.
From every individual, a total of 20 minutes of resting-state EEG was obtained.
EEG recordings were performed using a Neurosoft NEURON-SPECTRUM-4 device and Neuron-Spectrum.NET software.
Recordings were obtained from 19 electrode channels positioned according to the international 10-20 system: Fp1, Fp2, F7, F3, Fz, F4, F8, T7, C3, Cz, C4, T8, P7, P3, Pz, P4, P8, O1, O2.
Data were digitized at a sampling rate of 500 Hz.
Resting-state electroencephalography (EEG) microstate parameters, including mean duration, occurrence, coverage, and global explained variance (GEV) of microstate classes A-G, derived from 19-channel scalp EEG recordings using microstate analysis.
|
Baseline and immediately after the 20-minute tACS session.
|
|
Coma Recovery Scale-Revised (CRS-R)
Délai: Baseline and immediately after the 20-minute tACS session.
|
The CRS-R is a standardized clinical assessment tool used to evaluate the level of consciousness in patients with disorders of consciousness.
It consists of six subscales: auditory, visual, motor, oromotor/verbal, communication, and arousal.
The total score ranges from 0 to 23, with higher scores indicating a higher level of consciousness.
Diagnostic interpretation is based not only on the total score but also on the highest behavioral responses observed within each subscale.
|
Baseline and immediately after the 20-minute tACS session.
|
|
Simplified Evaluation of CONsciousness Disorders (SECONDs)
Délai: Baseline and immediately after the 20-minute tACS session.
|
The SECONDs is a brief bedside assessment designed for the rapid evaluation of patients with disorders of consciousness.
It assesses arousal and behavioral responses to simple commands and environmental stimuli.
The total score ranges from 0 to 8, with higher scores indicating a better level of consciousness.
It is a practical tool for screening and longitudinal clinical monitoring.
|
Baseline and immediately after the 20-minute tACS session.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Manifestations neurologiques
- Maladies du système nerveux
- Les troubles mentaux
- Manifestations neurocomportementales
- Troubles neurocognitifs
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Troubles de la conscience
- Thérapeutique
- Disciplines et activités comportementales
- Thérapie de stimulation électrique
- Thérapie convulsive
- Thérapies somatiques psychiatriques
- Électrochoc
- Techniques psychologiques
- Stimulation de courant direct transcrânien
Autres numéros d'identification d'étude
- 10840098-772.02-47943
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .